NanoString Technologies: establishing new UK headquarters in Amersham
NanoString Technologies (NSTG) provides tools for translational research and molecular diagnostics. Headquartered in Seattle and founded in 2003, the company began international sales operations in 2008, and in 2013 launched Prosigna™, its first in vitro diagnostic product for prognosis of early-stage breast cancer, in Europe...